105 related articles for article (PubMed ID: 17020964)
1. Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphoma.
Ruan J; Hyjek E; Kermani P; Christos PJ; Hooper AT; Coleman M; Hempstead B; Leonard JP; Chadburn A; Rafii S
Clin Cancer Res; 2006 Oct; 12(19):5622-31. PubMed ID: 17020964
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma.
Ruan J; Hajjar K; Rafii S; Leonard JP
Ann Oncol; 2009 Mar; 20(3):413-24. PubMed ID: 19088170
[TBL] [Abstract][Full Text] [Related]
3. Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes.
Gratzinger D; Zhao S; Marinelli RJ; Kapp AV; Tibshirani RJ; Hammer AS; Hamilton-Dutoit S; Natkunam Y
Am J Pathol; 2007 Apr; 170(4):1362-9. PubMed ID: 17392174
[TBL] [Abstract][Full Text] [Related]
4. Assessment of endothelial progenitor cells, VEGF-A and SDF-1α in Hodgkin's lymphoma.
Filipiak J; Boinska J; Ziołkowska K; Zduńska M; Zarychta E; Rość D
Blood Coagul Fibrinolysis; 2021 Jun; 32(4):266-272. PubMed ID: 33955861
[TBL] [Abstract][Full Text] [Related]
5. Transformation of indolent follicular lymphoma into diffuse large B-cell lymphoma - the molecular basis of "cancer aggressiveness".
Kledus F; Filip D; Mráz M
Klin Onkol; 2023; 36(4):353-363. PubMed ID: 37877527
[TBL] [Abstract][Full Text] [Related]
6. Stromal Cells Promote Neovascular Invasion Across Tissue Interfaces.
Strobel HA; LaBelle SA; Krishnan L; Dale J; Rauff A; Poulson AM; Bader N; Beare JE; Aliaj K; Weiss JA; Hoying JB
Front Physiol; 2020; 11():1026. PubMed ID: 33013445
[TBL] [Abstract][Full Text] [Related]
7. PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia.
McClanahan F; Hanna B; Miller S; Clear AJ; Lichter P; Gribben JG; Seiffert M
Blood; 2015 Jul; 126(2):203-11. PubMed ID: 25800048
[TBL] [Abstract][Full Text] [Related]
8. Vascular Growth in Lymphomas: Angiogenesis and Alternative Ways.
Ribatti D; Tamma R; Annese T; d'Amati A; Ingravallo G; Specchia G
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370872
[TBL] [Abstract][Full Text] [Related]
9. The role of Th17 cells in chronic lymphocytic leukemia: friend or foe?
Gamal W; Sahakian E; Pinilla-Ibarz J
Blood Adv; 2023 Jun; 7(11):2401-2417. PubMed ID: 36574293
[TBL] [Abstract][Full Text] [Related]
10. Activation and expansion of T-follicular helper cells in chronic lymphocytic leukemia nurselike cell co-cultures.
Vaca AM; Ioannou N; Sivina M; Vlachonikola E; Clise-Dwyer K; Kim E; Li D; Ma Q; Ferrajoli A; Estrov Z; Wierda WG; Patten PEM; Ramsay AG; Burger JA
Leukemia; 2022 May; 36(5):1324-1335. PubMed ID: 35149845
[TBL] [Abstract][Full Text] [Related]
11. Histomorphological and Morphometric Evaluation of Microvessel Density in Nodal Non-Hodgkin Lymphoma Using CD34 and CD105.
; Kataria SP; Malik S; Yadav R; Kapil R; Sen R
J Lab Physicians; 2021 Mar; 13(1):22-28. PubMed ID: 34149231
[No Abstract] [Full Text] [Related]
12. Immuno-oncology for B-cell lymphomas.
Choi YS
Blood Res; 2021 Apr; 56(S1):S70-S74. PubMed ID: 33935038
[TBL] [Abstract][Full Text] [Related]
13. Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy.
Apollonio B; Ioannou N; Papazoglou D; Ramsay AG
Front Oncol; 2021; 11():626818. PubMed ID: 33842331
[TBL] [Abstract][Full Text] [Related]
14. Angiogenesis in Lymph Nodes Is a Critical Regulator of Immune Response and Lymphoma Growth.
Menzel L; Höpken UE; Rehm A
Front Immunol; 2020; 11():591741. PubMed ID: 33343570
[TBL] [Abstract][Full Text] [Related]
15. Genetic and Non-Genetic Mechanisms of Resistance to BCR Signaling Inhibitors in B Cell Malignancies.
Ondrisova L; Mraz M
Front Oncol; 2020 Oct; 10():591577. PubMed ID: 33154951
[TBL] [Abstract][Full Text] [Related]
16. A super-SILAC based proteomics analysis of diffuse large B-cell lymphoma-NOS patient samples to identify new proteins that discriminate GCB and non-GCB lymphomas.
van der Meeren LE; Kluiver J; Rutgers B; Alsagoor Y; Kluin PM; van den Berg A; Visser L
PLoS One; 2019; 14(10):e0223260. PubMed ID: 31603917
[TBL] [Abstract][Full Text] [Related]
17. Dissecting the Prognostic Significance and Functional Role of Progranulin in Chronic Lymphocytic Leukemia.
Schulze-Edinghausen L; Dürr C; Öztürk S; Zucknick M; Benner A; Kalter V; Ohl S; Close V; Wuchter P; Stilgenbauer S; Lichter P; Seiffert M
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31200555
[TBL] [Abstract][Full Text] [Related]
18. Imaging VEGF Receptors and α
Tekabe Y; Li Q; Zhang G; Johnson J; Schmidt AM; Backer M; Backer J; Johnson LL
Mol Imaging Biol; 2018 Dec; 20(6):963-972. PubMed ID: 29687324
[TBL] [Abstract][Full Text] [Related]
19. Targeting B cell receptor signalling in cancer: preclinical and clinical advances.
Burger JA; Wiestner A
Nat Rev Cancer; 2018 Mar; 18(3):148-167. PubMed ID: 29348577
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival.
Trimarco V; Ave E; Facco M; Chiodin G; Frezzato F; Martini V; Gattazzo C; Lessi F; Giorgi CA; Visentin A; Castelli M; Severin F; Zambello R; Piazza F; Semenzato G; Trentin L
Oncotarget; 2015 Dec; 6(39):42130-49. PubMed ID: 26517523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
